Two Sigma Advisers’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Two Sigma Advisers’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-34,300	Closed	-$1.16M	–	2803
2021 Q2	$1.16M	Sell	34,300 -36,100	-51%	-$920K	﹤0.01%	1570
2021 Q1	$1.65M	Sell	70,400 -143,900	-67%	-$4.36M	﹤0.01%	1366
2020 Q4	$6.17M	Sell	214,300 -42,500	-17%	-$1.07M	0.02%	736
2020 Q3	$5.2M	Buy	256,800 +129,400	+102%	+$3.16M	0.01%	745
2020 Q2	$3.83M	Buy	127,400 +109,300	+604%	+$3.94M	0.01%	903
2020 Q1	$569K	Buy	+18,100	New	+$629K	﹤0.01%	1745

Two Sigma Advisers's CNST Position: Q3 2021 in Review

Two Sigma Advisers sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 34,300 shares — an estimated $1.16M sold.

Two Sigma Advisers first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $6.17M in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Two Sigma Advisers reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Two Sigma Advisers sold 34,300 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.16M.
Two Sigma Advisers first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
Two Sigma Advisers's Constellation Pharmaceuticals, Inc. position peaked at $6.17M in Q4 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.